|
|
发表于 12-11-2009 08:46 PM
|
显示全部楼层
原帖由 SUNNY仔 于 2009-11-6 12:47 AM 发表 
哇...你终于浮出水面啦...
很久没进来了，来看看最近网友们对股市意见咯~~ |
|
|
|
|
|
|
|
|
|
|
|
发表于 12-11-2009 11:36 PM
|
显示全部楼层
明年头会买进ctic。。不到四月前一定又会被炒高.!!
明年头，找一个低价，买进，就行了。 |
|
|
|
|
|
|
|
|
|
|
|
发表于 13-11-2009 09:25 AM
|
显示全部楼层
13/11/09
Cell Therapeutics, Inc. (CTIC) - I continue to watch CTIC but i'd rather watch paint dry. Support is located at $0.97 and resistance is $1.21. I will buy big time if CTIC can break above $1.21. Until then, I'm not touching it |
|
|
|
|
|
|
|
|
|
|
|
发表于 13-11-2009 02:01 PM
|
显示全部楼层
原帖由 miku 于 12-11-2009 11:36 PM 发表 
明年头会买进ctic。。不到四月前一定又会被炒高.!!
明年头，找一个低价，买进，就行了。
请问你打算几时请吃. |
|
|
|
|
|
|
|
|
|
|
|
发表于 13-11-2009 02:45 PM
|
显示全部楼层
|
|
|
|
|
|
|
|
|
|
|
发表于 13-11-2009 03:09 PM
|
显示全部楼层
|
|
|
|
|
|
|
|
|
|
|
发表于 13-11-2009 03:09 PM
|
显示全部楼层
|
|
|
|
|
|
|
|
|
|
|
发表于 13-11-2009 05:30 PM
|
显示全部楼层
|
|
|
|
|
|
|
|
|
|
|
发表于 13-11-2009 05:31 PM
|
显示全部楼层
|
|
|
|
|
|
|
|
|
|
|
发表于 13-11-2009 05:31 PM
|
显示全部楼层
|
^*%$$* $%*&%$*% #^##$*& (*^(^(*^(^(^ 587$^#@^& |
|
|
|
|
|
|
|
|
|
|
|
发表于 14-11-2009 12:12 PM
|
显示全部楼层
|
|
|
|
|
|
|
|
|
|
|
发表于 14-11-2009 03:51 PM
|
显示全部楼层
|
|
|
|
|
|
|
|
|
|
|
发表于 14-11-2009 03:52 PM
|
显示全部楼层
Last Night Future
YMZ09.CBT Mini Dow Jones Indus.-$5 Dec 09 10,242.00 Nov 13 Up 55.00 (0.54%) |
|
|
|
|
|
|
|
|
|
|
|
发表于 15-11-2009 01:07 PM
|
显示全部楼层
|
|
|
|
|
|
|
|
|
|
|
发表于 15-11-2009 09:48 PM
|
显示全部楼层
|
|
|
|
|
|
|
|
|
|
|
发表于 16-11-2009 09:30 AM
|
显示全部楼层
16/11/09
Cell Therapeutics, Inc. (CTIC) - CTIC continues to trade under $1.00, I would be a buyer on a break up through $1.21. |
|
|
|
|
|
|
|
|
|
|
|
发表于 17-11-2009 08:59 AM
|
显示全部楼层
17/11/09
Cell Therapeutics, Inc. (CTIC) - CTIC continues to trade under $1.00, I would be a buyer on a break up through $1.21. |
|
|
|
|
|
|
|
|
|
|
|
发表于 19-11-2009 09:33 AM
|
显示全部楼层
19/11/09
Cell Therapeutics, Inc. (CTIC) - Support = 1.00 - Resistance = $1.21 |
|
|
|
|
|
|
|
|
|
|
|
发表于 20-11-2009 05:47 PM
|
显示全部楼层
20/11/09
Cell Therapeutics, Inc. (CTIC) - Alert Alert! CTIC is actually showing signs of life! The stock continues to trend higher this weak and despite a horrible stock market Thursday, CTIC broke to a new weekly high at $1.14. Resistance is located at $1.14 which is the 50 day moving average as well as $1.21. A break above $1.21 would be huge and would cause me to jump back into the stock for a trade. |
|
|
|
|
|
|
|
|
|
|
|
发表于 20-11-2009 10:13 PM
|
显示全部楼层
好消息？ ？看股價會上多少。。。
Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group --CTI to seek recovery from
Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group --CTI to seek
recovery from The Lash Group for damages including reimbursement of prior expenses from the 2007 settlement
with United States government concerning TRISENOX
Fri Nov 20 03:30:00 2009
EST
SEATTLE, Nov 20, 2009 /PRNewswire-FirstCall via COMTEX News Network/ --
Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced today that the
Ninth Circuit Court of Appeals reversed a U.S. District Court order and ruled that
CTI should be allowed to pursue all of its claims against The Lash Group, sending
the case back to the District Court for trial. CTI filed a complaint against The
Lash Group, CTI's former third-party reimbursement consultant for CTI's product
TRISENOX, in 2007 seeking $22.8 million in damages for expenses already incurred
related to the investigation, defense and a settlement of claims by the U.S. government
concerning Medicare reimbursement for TRISENOX and other business losses.
In 2007, CTI settled the claims by the U.S. government without admitting
liability and filed a lawsuit including claims that The Lash Group had breached
its contractual obligations to CTI as related to its services, as well as an obligation
to indemnify the company for damages related to the settlement. CTI sold TRISENOX
in 2005 to Cephalon, Inc.
About Cell Therapeutics, Inc.
Headquartered in Seattle, CTI is a biopharmaceutical company committed to
developing an integrated portfolio of oncology products aimed at making cancer more
treatable. For additional information, please visit www.CellTherapeutics.com.
Sign up for email alerts and get RSS feeds at our Web site, http://www.CellTherapeutics.com/investors_alert
This press release includes forward-looking statements that involve a number
of risks and uncertainties, the outcome of which could materially and/or adversely
affect actual future results and the trading price of the securities of CTI. Specifically,
the risks and uncertainties include risks associated with preclinical and clinical
developments in the biopharmaceutical industry in general and the possibility that
CTI may not be successful in obtaining a judgment for damages and that The Lash
Group may appeal any award given, CTI's ability to continue to raise capital as
needed to fund its operations, competitive factors, technological developments,
costs of developing, producing and selling pixantrone, and the risk factors listed
or described from time to time in CTI's filings with the Securities and Exchange
Commission including, without limitation, CTI's most recent filings on Forms 10-K,
10-Q and 8-K. Except as may be required by law, CTI does not intend to update or
alter its forward-looking statements whether as a result of new information, future
events, or otherwise.
Media Contact: Investors Contact:
Dan Eramian Ed Bell
T: 206.272.4343 T: 206.272.4345
C: 206.854.1200 Lindsey Jesch Logan
F: 206.272.4434 T: 206.272.4347
E: deramian@ctiseattle.com F: 206.272.4434
www.celltherapeutics.com/press_room E: invest@ctiseattle.com
www.celltherapeutics.com/investors
SOURCE Cell Therapeutics, Inc.http://www.celltherapeutics.com
Copyright (C) 2009 PR Newswire. All rights reserved
CTIC, CEPH,
CA-CTIC-Wins-Federal, BUSINESS, csta+stories, financenews, financenews+select, HEALTHCARE, hedge+funds,
prn, PUBCO+SELECT, PUBLIC+COMPANIES, WALL+STREET, |
|
|
|
|
|
|
|
|
|
| |
 本周最热论坛帖子
|
1703 
27
